Covid-19 roundup: Ox­ford Bio­med­ica and As­traZeneca ex­tend vac­cine deal; FDA wants boost­ers for new­er vari­ants

An Ox­ford Uni­ver­si­ty spin­out and one of the ma­jor play­ers in the phar­ma in­dus­try are ex­tend­ing their col­lab­o­ra­tion on its Covid shot.

Ox­ford Bio­med­ica and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER